Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Escribano

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 13, 2015
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implicationsMaria Jara-Acevedo, Cristina Teodosio, Laura Sanchez-Muñoz, et al.
Oncotarget|October 6, 2017
Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 <i>KIT</i> mutations and review of the literatureIván Alvarez-Twose, Almudena Matito, José Mário Morgado, et al.
Archives of Dermatology|August 17, 2011
Dermoscopic features of skin lesions in patients with mastocytosisSergio Vano-Galvan, Iván Alvarez-Twose, Elena De las Heras, et al.
British Journal of Haematology|October 13, 2015
Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patientsLaura Sánchez-Muñoz, Jose M Morgado, Ivan Álvarez-Twose, et al.
Blood|December 2, 2015
KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progressionAndres C Garcia-Montero, Maria Jara-Acevedo, Ivan Alvarez-Twose, et al.
Plos One|October 25, 2013
Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeAlmudena Matito, José Mario Morgado, Iván Álvarez-Twose, et al.
Blood|June 3, 2006
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsAndres C Garcia-Montero, Maria Jara-Acevedo, Cristina Teodosio, et al.
Case Reports in Hematology|April 20, 2018
<i>KIT</i> D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid LeukemiaMarta Lopes, Maria Dos Anjos Teixeira, Cláudia Casais, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2011
Evaluation of the WHO criteria for the classification of patients with mastocytosisLaura Sánchez-Muñoz, Ivan Alvarez-Twose, Andrés C García-Montero, et al.
International Journal of Molecular Sciences|January 31, 2019
Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic MastocytosisNoelia Dasilva-Freire, Andrea Mayado, Cristina Teodosio, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 13, 2015
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implicationsMaria Jara-Acevedo, Cristina Teodosio, Laura Sanchez-Muñoz, et al.
Oncotarget|October 6, 2017
Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 <i>KIT</i> mutations and review of the literatureIván Alvarez-Twose, Almudena Matito, José Mário Morgado, et al.
Archives of Dermatology|August 17, 2011
Dermoscopic features of skin lesions in patients with mastocytosisSergio Vano-Galvan, Iván Alvarez-Twose, Elena De las Heras, et al.
British Journal of Haematology|October 13, 2015
Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patientsLaura Sánchez-Muñoz, Jose M Morgado, Ivan Álvarez-Twose, et al.
Blood|December 2, 2015
KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progressionAndres C Garcia-Montero, Maria Jara-Acevedo, Ivan Alvarez-Twose, et al.
Plos One|October 25, 2013
Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeAlmudena Matito, José Mario Morgado, Iván Álvarez-Twose, et al.
Blood|June 3, 2006
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsAndres C Garcia-Montero, Maria Jara-Acevedo, Cristina Teodosio, et al.
Case Reports in Hematology|April 20, 2018
<i>KIT</i> D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid LeukemiaMarta Lopes, Maria Dos Anjos Teixeira, Cláudia Casais, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2011
Evaluation of the WHO criteria for the classification of patients with mastocytosisLaura Sánchez-Muñoz, Ivan Alvarez-Twose, Andrés C García-Montero, et al.
International Journal of Molecular Sciences|January 31, 2019
Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic MastocytosisNoelia Dasilva-Freire, Andrea Mayado, Cristina Teodosio, et al.
Pageof 7